{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:53:11Z","timestamp":1785851591854,"version":"3.56.0"},"reference-count":44,"publisher":"American Chemical Society (ACS)","issue":"30","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA212379"],"award-info":[{"award-number":["R01CA212379"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA218615"],"award-info":[{"award-number":["R01CA218615"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Institute of Health","doi-asserted-by":"publisher","award":["EB0033000"],"award-info":[{"award-number":["EB0033000"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite a few clinical successes, the efficacy of cancer nanomedicines remains limited by rapid clearance by the mononuclear phagocytic system and poor permeation across the abnormal tumor vasculature. We previously showed that methyl palmitate nanoparticles (MPN) can safely and reversibly inhibit the phagocytic activity of immune cells for several hours, thereby improving tumor accumulation and the efficacy of systemically administered nanomedicines. Here, we demonstrate that, on a shorter time scale, MPN can induce vasodilation, introducing an additional mechanism to enhance the accumulation of therapeutic agents within malignant tissue. Upon internalization by macrophages and endothelial cells, MPN could potentially trigger the release of endogenous nitric oxide (NO), a key mediator of vasodilation, in a concentration-, and time-dependent manner. Following MPN administration, raster-scanning optoacoustic mesoscopy (RSOM) revealed vasodilation across multiple tissues, with a strong effect observed in tumors. To assess enhanced tumor accumulation, we injected 70 kDa fluorescent dextran and demonstrated via histology a markedly increased fluorescence signal exclusively in MPN-treated tumors compared to controls 24 h later. In addition, positron emission tomography (PET) imaging of 89Zr-labeled Feraheme nanoparticles showed significantly greater tumor accumulation after a 15 min MPN pretreatment. Finally, general serum biochemistry panels and histological analyses of major organs in healthy mice revealed that MPN did not induce observable short-term toxicity under the tested conditions (single or repeated MPN dosing). Overall, this study demonstrates that MPN-induced vasodilation occurring within minutes enhances intratumoral deposition of macromolecules and small nanoparticles. Together with their longer-term effects on phagocytosis inhibition, these findings indicate that MPN can improve therapeutic delivery through complementary, time-dependent mechanisms that increase tumor perfusion and vascular permeability.<\/jats:p>","DOI":"10.1021\/acsnano.6c03988","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:05:23Z","timestamp":1784315123000},"page":"21172-21188","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Tumor\nPerfusion and Nanomedicine Delivery\nby Modulating Vascular Tone with Methyl Palmitate Nanoparticles"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9715-3876","authenticated-orcid":true,"given":"Roberto","family":"Palomba","sequence":"first","affiliation":[{"name":"Laboratory of Nanotechnology for Precision Medicine \u2212 Fondazione Istituto Italiano di Tecnologia , Via Morego 30 , ,","place":["Genova, Italy, 16163"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Isaac","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-8164","authenticated-orcid":true,"given":"Raffaele","family":"Spano\u0300","sequence":"additional","affiliation":[{"name":"Laboratory of Nanotechnology for Precision Medicine \u2212 Fondazione Istituto Italiano di Tecnologia , Via Morego 30 , ,","place":["Genova, Italy, 16163"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Piccardi","sequence":"additional","affiliation":[{"name":"Laboratory of Nanotechnology for Precision Medicine \u2212 Fondazione Istituto Italiano di Tecnologia , Via Morego 30 , ,","place":["Genova, Italy, 16163"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-7431","authenticated-orcid":true,"given":"Benedict","family":"McLarney","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Apfelbaum","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ting","family":"Hsu","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-9385","authenticated-orcid":true,"given":"Jan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program , , 1275 York Avenue , , ,","place":["New York City, New York, United States, Z2025"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-4188","authenticated-orcid":true,"given":"Paolo","family":"Decuzzi","sequence":"additional","affiliation":[{"name":"Laboratory of Nanotechnology for Precision Medicine \u2212 Fondazione Istituto Italiano di Tecnologia , Via Morego 30 , ,","place":["Genova, Italy, 16163"]},{"name":"Stanford University , , 269 Campus Drive , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026080409282630300_cit1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design\nfor overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"2026080409282630300_cit2","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1039\/D1MH00937K","article-title":"Boosting nanomedicine performance by conditioning macrophages with\nmethyl palmitate nanoparticles","volume":"8","author":"Palomba","year":"2021","journal-title":"Mater. Horiz."},{"key":"2026080409282630300_cit3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.nano.2011.07.009","article-title":"Uptake of nanoparticles\nby alveolar macrophages is triggered by surfactant\nprotein A","volume":"7","author":"Ruge","year":"2011","journal-title":"Nanomedicine"},{"key":"2026080409282630300_cit4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2217\/nnm.12.111","article-title":"Complex Encounters:\nNanoparticles in Whole Blood and Their Uptake\nInto Different Types of White Blood Cells","volume":"8","author":"Baumann","year":"2013","journal-title":"Nanomedicine"},{"key":"2026080409282630300_cit5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0065-2377(08)60214-8","article-title":"Transport\nPhenomena in Tumors","volume":"19","author":"Jain","year":"1994","journal-title":"Adv. Chem. Eng."},{"key":"2026080409282630300_cit6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of Molecular\nand Nanoscale Medicine to Tumors: Transport Barriers and Strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"2026080409282630300_cit7","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Coevolution of Solid\nStress and Interstitial Fluid Pressure in Tumors\nDuring Progression: Implications for Vascular Collapse","volume":"73","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"key":"2026080409282630300_cit8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","article-title":"The unique\ncharacteristics of tumor vasculature and preclinical evidence for\nits selective disruption by Tumor-Vascular Disrupting Agents","volume":"37","author":"Siemann","year":"2011","journal-title":"Cancer Treat Rev."},{"key":"2026080409282630300_cit9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing Function\nof Tumor Vessels:\nProgress, Opportunities, and Challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu.\nRev. Physiol."},{"key":"2026080409282630300_cit10","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the tumor microenvironment by harnessing vascular\nand immune modulation to achieve enhanced cancer therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"2026080409282630300_cit11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves\nthe delivery of nanomedicines\nin a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"2026080409282630300_cit12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2218847120","article-title":"Nonspherical ultrasound\nmicrobubbles","volume":"120","author":"Dasgupta","year":"2023","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"key":"2026080409282630300_cit13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jconrel.2022.05.022","article-title":"NO-dependent vasodilation and deep tumor penetration for cascade-amplified\nantitumor performance","volume":"347","author":"Xu","year":"2022","journal-title":"J. Controlled Release"},{"key":"2026080409282630300_cit14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphar.2012.00094","article-title":"Targeting Tumor Perfusion\nand Oxygenation to Improve\nthe Outcome of Anticancer Therapy1","volume":"3","author":"Jordan","year":"2012","journal-title":"Front. Pharmacol."},{"key":"2026080409282630300_cit15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/oxfordjournals.annonc.a059043","article-title":"Microvessel density, endothelial cell proliferation\nand tumour cell\nproliferation in human colorectal adenocarcinomas *","volume":"6","author":"Vermeulen","year":"1995","journal-title":"Ann. Oncol."},{"key":"2026080409282630300_cit16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2013.00211","article-title":"Vascular Permeability\nand Drug Delivery\nin Cancers","volume":"3","author":"Azzi","year":"2013","journal-title":"Front. Oncol."},{"key":"2026080409282630300_cit17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cas.12577","article-title":"Poly-S-nitrosated human\nalbumin enhances the antitumor and antimetastasis\neffect of bevacizumab, partly by inhibiting autophagy through the\ngeneration of nitric oxide","volume":"106","author":"Ishima","year":"2015","journal-title":"Cancer Sci."},{"key":"2026080409282630300_cit18","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1158\/1535-7163.MCT-18-0696","article-title":"Augmentation of the\nEnhanced Permeability and Retention Effect with\nNitric Oxide\u2013Generating Agents Improves the Therapeutic Effects\nof Nanomedicines","volume":"17","author":"Islam","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"2026080409282630300_cit19","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric Oxide\nDonor-Based Cancer Therapy: Advances and\nProspects","volume":"60","author":"Huang","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026080409282630300_cit20","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1167\/iovs.09-5132","article-title":"Methyl Palmitate: A\nPotent Vasodilator Released in the Retina","volume":"51","author":"Lee","year":"2010","journal-title":"Invest.\nOphthalmol. Vis. Sci."},{"key":"2026080409282630300_cit21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fphys.2018.00583","article-title":"Palmitic Acid Methyl\nEster and Its Relation to Control of Tone of Human Visceral Arteries\nand Rat Aortas by Perivascular Adipose Tissue","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Physiol."},{"key":"2026080409282630300_cit22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43094-020-00044-y","article-title":"Putative anti-inflammatory, antioxidant,\nand anti-apoptotic\nroles of the natural tissue guardian methyl palmitate against isoproterenol-induced\nmyocardial injury in rats","volume":"6","author":"Hamed","year":"2020","journal-title":"Future J. Pharm.\nSci."},{"key":"2026080409282630300_cit23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1021\/acsnano.7b07797","article-title":"Modulating Phagocytic Cell Sequestration by Tailoring\nNanoconstruct\nSoftness","volume":"12","author":"Palomba","year":"2018","journal-title":"ACS Nano"},{"key":"2026080409282630300_cit24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11095-008-9697-x","article-title":"Intravascular Delivery\nof Particulate Systems: Does Geometry Really Matter?","volume":"26","author":"Decuzzi","year":"2009","journal-title":"Pharm. Res."},{"issue":"13","key":"2026080409282630300_cit25","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target\ngeometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"key":"2026080409282630300_cit26","doi-asserted-by":"publisher","DOI":"10.1159\/000551278","article-title":"Methyl Palmitate, a Potent\nAngiotensin Converting Enzyme Inhibitor, Attenuates Vascular Remodeling\nin L-NG-Nitro Arginine Methyl Ester-Induced Hypertensive Wistar Rat\nModels","author":"Rao","year":"2026","journal-title":"J. Vasc. Res."},{"key":"2026080409282630300_cit27","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12686","article-title":"Methyl palmitate\nmodulates the nicotine-induced increase in basilar arterial blood\nflow","volume":"28","author":"Chun-Kai","year":"2021","journal-title":"Microcirculation"},{"key":"2026080409282630300_cit28","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1021\/acsnano.9b07233","article-title":"Differential Nanoparticle Sequestration by Macrophages and Scavenger\nEndothelial Cells Visualized in Vivo in Real-Time and at Ultrastructural\nResolution","volume":"14","author":"Hayashi","year":"2020","journal-title":"ACS Nano"},{"key":"2026080409282630300_cit29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle\nuptake: The phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"2026080409282630300_cit30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41551-020-0527-8","article-title":"High-resolution\noptoacoustic imaging of tissue responses to vascular-targeted therapies","volume":"4","author":"Haedicke","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"2026080409282630300_cit31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.7150\/thno.95334","article-title":"Vascularized tumor on\na microfluidic chip to study mechanisms promoting\ntumor neovascularization and vascular targeted therapies","volume":"15","author":"Skubal","year":"2025","journal-title":"Theranostics"},{"key":"2026080409282630300_cit32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41565-019-0406-1","article-title":"FDA-approved ferumoxytol displays anti-leukaemia efficacy against\ncells with low ferroportin levels","volume":"14","author":"Trujillo-Alonso","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"2026080409282630300_cit33","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1021\/acsnano.2c05800","article-title":"Translatable Drug-Loaded\nIron Oxide Nanophore Sensitizes Murine Melanoma\nTumors to Monoclonal Antibody Immunotherapy","volume":"17","author":"Stater","year":"2023","journal-title":"ACS Nano"},{"key":"2026080409282630300_cit34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory\nmacrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat.\nNanotechnol."},{"key":"2026080409282630300_cit35","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1038\/ncomms4384","article-title":"Environment-responsive nanophores for therapy and treatment monitoring\nvia molecular MRI quenching","volume":"5","author":"Kaittanis","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"2026080409282630300_cit36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172722","article-title":"Heat-induced-radiolabeling\nand click chemistry: A powerful combination for generating multifunctional\nnanomaterials","volume":"12","author":"Yuan","year":"2017","journal-title":"PLoS One"},{"key":"2026080409282630300_cit37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1039\/C4SC02778G","article-title":"Chelate-free\nmetal ion binding and heat-induced radiolabeling of iron oxide nanoparticles","volume":"6","author":"Boros","year":"2015","journal-title":"Chem. Sci."},{"key":"2026080409282630300_cit38","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.bbadis.2018.05.003","article-title":"The role of\nxanthine oxidoreductase and uric acid in metabolic syndrome","volume":"1864","author":"Battelli","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"2026080409282630300_cit39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/10715769409056572","article-title":"Nitric Oxide\nReversibly Suppresses Xanthine Oxidase Activity","volume":"21","author":"Fukahori","year":"1994","journal-title":"Free Radic. Res."},{"issue":"7","key":"2026080409282630300_cit40","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0735-1097(01)01643-6","article-title":"Uric acid is closely linked to vascular\nnitric oxide\nactivity. Evidence for mechanism of association with cardiovascular\ndisease","volume":"38","author":"Maxwell","year":"2001","journal-title":"J. Am. College Cardiol."},{"key":"2026080409282630300_cit41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.niox.2013.04.003","article-title":"Uric acid attenuates\nnitric oxide production by decreasing the interaction\nbetween endothelial nitric oxide synthase and calmodulin in human\numbilical vein endothelial cells: A mechanism for uric acid-induced\ncardiovascular disease development","volume":"32","author":"Park","year":"2013","journal-title":"Nitric.\nOxide"},{"key":"2026080409282630300_cit42","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1021\/la304746p","article-title":"Margination\nPropensity of Vascular-Targeted Spheres from Blood Flow in a Microfluidic\nModel of Human Microvessels","volume":"29","author":"Namdee","year":"2013","journal-title":"Langmuir"},{"key":"2026080409282630300_cit43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-3155-6-9","article-title":"The margination\npropensity of spherical particles for vascular targeting in the microcirculation","volume":"6","author":"Gentile","year":"2008","journal-title":"J. Nanobiotechnol."},{"key":"2026080409282630300_cit44","unstructured":"AMAG Pharmaceuticals, Inc.\n          \n          Feraheme\n(ferumoxytol\ninjection), for intravenous use [prescribing information]; 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/022180s025lbl.pdf. (accessed May 24, 2026)."}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.6c03988","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/30\/21172\/66014483\/acsnano.6c03988.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/30\/21172\/66014483\/acsnano.6c03988.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:28:37Z","timestamp":1785850117000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/30\/21172\/5214747\/Enhancing-Tumor-Perfusion-and-Nanomedicine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":44,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.6c03988","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}